Oppenheimer analyst Hartaj Singh maintained a Buy rating on Pharming Group (PHAR) yesterday and set a price target of $43.00.
The post Pharming Group (PHAR) Gets a Buy Rating from Oppenheimer appeared first on Smarter Analyst.
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Pharming ...

https://www.smarteranalyst.com/new-blurbs/pharming-group-phar-gets-a-buy-rating-from-oppenheimer/

#SmarterAnalyst